Biotron Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Biotron's earnings have been declining at an average annual rate of -2.6%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 22.9% per year.
Anahtar bilgiler
-2.6%
Kazanç büyüme oranı
6.0%
EPS büyüme oranı
| Biotechs Sektör Büyümesi | 9.6% |
| Gelir büyüme oranı | 22.9% |
| Özkaynak getirisi | n/a |
| Net Marj | -208.9% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Feb 27
We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth
Oct 20We're Not Worried About Biotron's (ASX:BIT) Cash Burn
Jul 06Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jan 18Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jul 06Here's Why We're Watching Biotron's (ASX:BIT) Cash Burn Situation
Mar 17Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Nov 27Biotron (ASX:BIT) Is In A Good Position To Deliver On Growth Plans
May 26We're Not Very Worried About Biotron's (ASX:BIT) Cash Burn Rate
Feb 10What Can We Conclude About Biotron's (ASX:BIT) CEO Pay?
Dec 19Gelir ve Gider Dağılımı
Biotron nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -3 | 1 | 4 |
| 31 Mar 24 | 2 | -4 | 1 | 4 |
| 31 Dec 23 | 2 | -4 | 1 | 4 |
| 30 Sep 23 | 2 | -4 | 2 | 4 |
| 30 Jun 23 | 1 | -3 | 2 | 3 |
| 31 Mar 23 | 2 | -3 | 1 | 3 |
| 31 Dec 22 | 3 | -2 | 1 | 3 |
| 30 Sep 22 | 2 | -2 | 1 | 3 |
| 30 Jun 22 | 2 | -3 | 1 | 3 |
| 31 Mar 22 | 1 | -3 | 1 | 3 |
| 31 Dec 21 | 1 | -3 | 1 | 3 |
| 30 Sep 21 | 1 | -3 | 1 | 3 |
| 30 Jun 21 | 1 | -3 | 1 | 3 |
| 31 Mar 21 | 1 | -4 | 1 | 3 |
| 31 Dec 20 | 1 | -4 | 1 | 3 |
| 30 Sep 20 | 1 | -4 | 1 | 3 |
| 30 Jun 20 | 1 | -4 | 1 | 3 |
| 31 Mar 20 | 0 | -3 | 1 | 2 |
| 31 Dec 19 | 0 | -3 | 1 | 2 |
| 30 Sep 19 | 1 | -3 | 1 | 2 |
| 30 Jun 19 | 1 | -2 | 1 | 1 |
| 31 Mar 19 | 1 | -2 | 1 | 1 |
| 31 Dec 18 | 1 | -2 | 1 | 1 |
| 30 Sep 18 | 1 | -2 | 1 | 1 |
| 30 Jun 18 | 2 | -2 | 1 | 2 |
| 31 Mar 18 | 2 | -1 | 1 | 2 |
| 31 Dec 17 | 3 | -1 | 1 | 3 |
| 30 Sep 17 | 2 | -2 | 1 | 3 |
| 30 Jun 17 | 2 | -3 | 1 | 3 |
| 31 Mar 17 | 2 | -3 | 1 | 3 |
| 31 Dec 16 | 2 | -2 | 1 | 2 |
| 30 Sep 16 | 2 | -3 | 1 | 3 |
| 30 Jun 16 | 2 | -3 | 1 | 3 |
| 31 Mar 16 | 2 | -3 | 1 | 3 |
| 31 Dec 15 | 2 | -3 | 1 | 3 |
| 30 Sep 15 | 2 | -3 | 1 | 3 |
| 30 Jun 15 | 2 | -3 | 1 | 3 |
| 31 Mar 15 | 2 | -3 | 1 | 3 |
| 31 Dec 14 | 2 | -3 | 1 | 3 |
| 30 Sep 14 | 2 | -3 | 1 | 3 |
| 30 Jun 14 | 2 | -3 | 1 | 3 |
| 31 Mar 14 | 1 | -4 | 1 | 3 |
| 31 Dec 13 | 1 | -4 | 1 | 4 |
Kaliteli Kazançlar: BIT is currently unprofitable.
Büyüyen Kar Marjı: BIT is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: BIT is unprofitable, and losses have increased over the past 5 years at a rate of 2.6% per year.
Büyüme Hızlandırma: Unable to compare BIT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: BIT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.5%).
Özkaynak Getirisi
Yüksek ROE: BIT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.